2 purchases reported after at least 12 months of silence — most recent on 13 Nov 2023.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Janux Therapeutics, Inc. | 633,673 | reported | 03 Jun 2024 | tx 11+5,713,096−3,828,249 |
| Synthorx, Inc. | 0 | reported | 23 Jan 2020 | tx 8+1,712,086−3,595,653 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Jun 2024 | SALE | Janux Therapeutics, Inc. | 691,525 | 54.75 USD | |
| 03 Jun 2024 | SALE | Janux Therapeutics, Inc. | 131,196 | 54.75 USD | |
| 02 Jan 2024 | GRANT_AWARD | Janux Therapeutics, Inc. | 157,000 | 0.00 USD | deriv |
| 13 Nov 2023 | PURCHASE | Janux Therapeutics, Inc. | 849,854 | 5.87 USD | first after silence |
| 03 Jan 2023 | GRANT_AWARD | Janux Therapeutics, Inc. | 110,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Janux Therapeutics, Inc. | 116,750 | 0.00 USD | deriv |
| 15 Jun 2021 | PURCHASE | Janux Therapeutics, Inc. | 629,411 | 17.00 USD | first after silence |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 1,153,238 | — |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 2,696,843 | — |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 900,264 | — | deriv |
| 15 Jun 2021 | CONVERSION | Janux Therapeutics, Inc. | 2,105,264 | — | deriv |
| 23 Jan 2020 | TENDER | Synthorx, Inc. | 43,688 | 68.00 USD |
| 23 Jan 2020 | TENDER | Synthorx, Inc. | 1,682,086 | 68.00 USD |
| 23 Jan 2020 | OTHER | Synthorx, Inc. | 18,723 | 63.36 USD | deriv |
| 23 Jan 2020 | OTHER | Synthorx, Inc. | 30,000 | 57.00 USD | deriv |
| 11 Dec 2018 | PURCHASE | Synthorx, Inc. | 545,455 | 11.00 USD |
| 11 Dec 2018 | CONVERSION | Synthorx, Inc. | 1,136,631 | — |
| 11 Dec 2018 | CONVERSION | Synthorx, Inc. | 1,821,156 | 0.00 USD | deriv |
| 06 Dec 2018 | GRANT_AWARD | Synthorx, Inc. | 30,000 | 0.00 USD | deriv |